News & Events
November 6, 2019
POST GRANT PROCEEDINGS SERIES Is IPR the best decision for me? By: Emily Gaukstern The America Invents Act (AIA), put into effect September 16, 2012, […]
October 29, 2019
ALLERGAN BATTLES TO KEEP BOTOX-MANUFACTURING PROCESS A TRADE SECRET By: Emily Gaukstern Allergan Plc (“Allergan”) has filed a motion challenging a trade judge’s […]
October 7, 2019
CAFC TO HEAR MEDTECH PATENT DISPUTE BETWEEN 23ANDME, INC. V. ANCESTRY.COM DNA, LLC By: Katie Rubino On October 2nd, 2019 oral arguments commenced at […]
September 11, 2019
Patent Attorney Milton Oliver Joins Caldwell IP Law Vermont Team Caldwell IP Law is pleased to announce that Milton Oliver has joined the firm […]
August 27, 2019
Biotech and IP: Financing and Strategy For many budding biotech entrepreneurs, the business side of launching a biotech startup can seem foreign and intimidating. While a […]
August 15, 2019
Launching your biotech start-up is an exciting, albeit overwhelming, venture. Eager entrepreneurs often struggle to navigate the labyrinth of tasks necessary to getting a startup off the […]
July 29, 2019
CAFC Rules Suboxone Patent is Not Infringed by Generic Buprenorphine Film Product By: Katie Rubino Recently on July 9th the Court of Appeals for […]
July 8, 2019
Patent Strategies for Small Molecule Drugs Versus Biological Drugs By: Katie Rubino Molecules used as drug products are often categorized into two classes: small […]
June 11, 2019
CAFC Affirms Invalidation of Oxycodone Patent for Lack of Written Description By: Katie Rubino On April 19th, 2019 the Court of Appeals of the Federal […]
May 28, 2019
Supreme Court Denies Certiorari Petition on Tribal Sovereign Immunity in IPR Proceedings By: Katie Rubino Recently at the end of April, the Supreme Court denied […]